| Q38740331 | A simple method to induce hypoxia-induced vascular endothelial growth factor-A (VEGF-A) expression in T24 human bladder cancer cells. |
| Q39659310 | Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment |
| Q36318719 | Anthracycline inhibits recruitment of hypoxia-inducible transcription factors and suppresses tumor cell migration and cardiac angiogenic response in the host |
| Q49721789 | Association between lysyl oxidase and fibrotic focus in relation with inflammation in breast cancer |
| Q39388167 | Coevolution of the tumor microenvironment revealed by quantum dot-based multiplexed imaging of hepatocellular carcinoma |
| Q91605292 | Combatting Fibrosis: Exosome-Based Therapies in the Regression of Liver Fibrosis |
| Q54850005 | Crystal structure of human lysyl oxidase-like 2 (hLOXL2) in a precursor state |
| Q37687619 | Dormant tumor cells expressing LOXL2 acquire a stem-like phenotype mediating their transition to proliferative growth. |
| Q86126484 | Effects of lysyl oxidase genetic variants on the susceptibility to rhegmatogenous retinal detachment and proliferative vitreoretinopathy |
| Q37520614 | Emerging role of LOXL2 in the promotion of pancreas cancer metastasis |
| Q36504341 | Exosomes from hypoxic endothelial cells have increased collagen crosslinking activity through up-regulation of lysyl oxidase-like 2 |
| Q93384360 | Extracellular Processing of Lysyl Oxidase-like 2 and Its Effect on Amine Oxidase Activity |
| Q34355294 | High glucose increases lysyl oxidase expression and activity in retinal endothelial cells: mechanism for compromised extracellular matrix barrier function |
| Q38177145 | Human copper-dependent amine oxidases. |
| Q38242121 | Human lysyl oxidase-like 2. |
| Q64964306 | Identification of two molecular subtypes in canine mast cell tumours through gene expression profiling. |
| Q51319814 | Increased lysyl oxidase-like 2 associates with a poor prognosis in non-small cell lung cancer. |
| Q36398681 | Inhibition of BMP signaling suppresses metastasis in mammary cancer |
| Q41957208 | LOXL2 catalytically inactive mutants mediate epithelial-to-mesenchymal transition. |
| Q39112374 | LOXL2 expression is associated with invasiveness and negatively influences survival in breast cancer patients. |
| Q34303455 | LOXL2 in epithelial cell plasticity and tumor progression |
| Q37690525 | LOXL2 induces aberrant acinar morphogenesis via ErbB2 signaling |
| Q37346579 | LOXL2-mediated matrix remodeling in metastasis and mammary gland involution |
| Q38723997 | Lysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and Cancer |
| Q46907178 | Lysyl Oxidase-like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer |
| Q46047137 | Lysyl Oxidase-like-2 Cross-links Collagen IV of Glomerular Basement Membrane. |
| Q36284915 | Lysyl oxidase, extracellular matrix remodeling and cancer metastasis |
| Q24298337 | Lysyl oxidase-like 2 (LOXL2) controls tumor-associated cell proliferation through the interaction with MARCKSL1 |
| Q34197948 | Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas |
| Q35527142 | Lysyl oxidase-like 2 represses Notch1 expression in the skin to promote squamous cell carcinoma progression. |
| Q24321781 | Lysyl oxidase-like protein-2 regulates sprouting angiogenesis and type IV collagen assembly in the endothelial basement membrane |
| Q28587970 | Lysyl oxidase-like-2 (LOXL2) is a major isoform in chondrocytes and is critically required for differentiation |
| Q47141583 | Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis |
| Q37233956 | MCF-7 cells expressing nuclear associated lysyl oxidase-like 2 (LOXL2) exhibit an epithelial-to-mesenchymal transition (EMT) phenotype and are highly invasive in vitro. |
| Q38344322 | Modulation of lysyl oxidase-like 2 enzymatic activity by an allosteric antibody inhibitor |
| Q38597172 | Proteolytic Processing of Lysyl Oxidase like-2 in the Extracellular Matrix is Required for Crosslinking of Basement Membrane Collagen IV. |
| Q33624937 | Roles of Copper-Binding Proteins in Breast Cancer |
| Q64057340 | Specific protein 1(SP1) regulates the epithelial-mesenchymal transition via lysyl oxidase-like 2(LOXL2) in pancreatic ductal adenocarcinoma |
| Q33599056 | Stem cell associated gene expression in glioblastoma multiforme: relationship to survival and the subventricular zone |
| Q34376252 | The Comparison of The Effects of Silybin and Silybin-Phosphatidylcholine on Viability and ESR Expression in Human Breast Cancer T47D Cell Line |
| Q118108008 | The functional and evolutionary impacts of human-specific deletions in conserved elements |
| Q33673803 | The lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia: insights into cellular transformation processes mediated by HIF-1 |
| Q51701163 | The potential for LOXL2 as a target for future cancer treatment. |
| Q38027412 | The rationale for targeting the LOX family in cancer |
| Q42118077 | ZEB1 induces LOXL2-mediated collagen stabilization and deposition in the extracellular matrix to drive lung cancer invasion and metastasis. |